These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7491346)
1. ["Prognostic markers" in serum of active and passive intravenous drug users infected with human immunodeficiency virus (HIV)]. Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Chodynicka B; Rogowski F; Kramarz P Pol Arch Med Wewn; 1995 Jun; 93(6):469-74. PubMed ID: 7491346 [TBL] [Abstract][Full Text] [Related]
2. [Levels of neopterin in serum of narcotics abusers infected with human immunodeficiency virus (HIV)]. Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Grzeszczuk A; Chodynicka B; Rogowski F; Kramarz P Pol Arch Med Wewn; 1994 May; 91(5):363-6. PubMed ID: 8084813 [TBL] [Abstract][Full Text] [Related]
3. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535 [TBL] [Abstract][Full Text] [Related]
4. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study. De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199 [TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection. Chironna M; Fanelli M; Potenza D; Serio G; Quarto M Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434 [TBL] [Abstract][Full Text] [Related]
7. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users. Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538 [No Abstract] [Full Text] [Related]
10. Markers for disease progression in intravenous drug users infected with HIV-1. Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652 [TBL] [Abstract][Full Text] [Related]
11. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers. Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599 [TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children? Chan MM; Campos JM; Josephs S; Rifai N J Clin Microbiol; 1990 Oct; 28(10):2215-9. PubMed ID: 2229344 [TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum beta 2-microglobulin in HIV infection. Krämer A; Goedert JJ; Wachter H; Fuchs D Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663 [No Abstract] [Full Text] [Related]
15. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441 [TBL] [Abstract][Full Text] [Related]
16. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
17. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in HIV-infected heroin addicts: a multivariate analysis of nonspecific serological factors in the evolution of the infection]. Echániz P; Larrañaga P; Arrizabalaga J; Jiménez JL; Iribarren JA; Cuadrado E Rev Clin Esp; 1992 May; 190(8):422-6. PubMed ID: 1620946 [TBL] [Abstract][Full Text] [Related]
19. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections. Carstens J; Andersen PL Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900 [TBL] [Abstract][Full Text] [Related]
20. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]